TheraPanacea
@therapanacea.us
TheraPanacea is an innovative information technology company devoted to unlocking the power of AI-based solutions to drive innovation in healthcare. A spin-off of University Paris-Saclay, TheraPanacea works in close cooperation with the most prominent healthcare facilities to combine the power of its proprietary platforms with clinical domain-knowledge. Today, ART-Plan™, TheraPanacea dedicated suite for radio-oncology, is used by more than 60 cancer centres across Europe, Africa, Middle-East and the US and is helping to improve care for more than 60,000 patients every year. TheraPanacea also develops and operates the ART-Omics™ platform enabling pharmaceutical companies to accelerate clinical research by harnessing AI-based multi-modality biomarker discovery in clinical trials and their effective integration within the clinical workflow at scale in the form of certified medical devices.
TheraPanacea's Company Logos
TheraPanacea's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#0C88A8
Blue Chill
12, 136, 168
192, 87, 35
93, 19, 0, 34
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#04303B
Blue Whale
4, 48, 59
192, 87, 12
93, 19, 0, 77
About TheraPanacea
TheraPanacea is a science-driven technology company focused on applying artificial intelligence to oncology and helping transform cancer care. Its work brings together expertise in advanced mathematics, medical imaging, software, and engineering, with products co-designed alongside clinicians. The company collaborates with clinical teams at cancer centers worldwide to develop and validate applications for radiotherapy.
Its ART-Plan™ platform is an AI application suite designed to support radiotherapy workflows. The suite includes automated segmentation to delineate anatomical structures and treatment targets, planning tools to generate treatment plans, and adaptive capabilities for assessing and monitoring treatment and supporting replanning. TheraPanacea aims to help clinicians streamline workflows, make data-informed decisions, and deliver high-quality care.
The company’s stated direction includes accelerating end-to-end workflows for adaptive radiotherapy, while exploring AI-driven decisions and treatment strategies for radiopharmaceutical therapy and precision medicine. TheraPanacea emphasizes sustained scientific investment and technology that delivers practical value for patients, clinicians, and healthcare systems.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
